Concepts

Allergy treatment and prevention

Hydrolysed proteins are vital in formulas that target infants diagnosed with an allergy to bovine milk proteins or identified as being in the allergy risk group. For such infants, hydrolysates or free amino acids are the available options. Hydrolysates have the better taste, and, as studies have shown they are more readily absorbed than free amino acids or intact proteins.

The incidence of cow’s milk allergy has been estimated to be ~2-3% of the population, and the prevalence is increasing. In order to treat and prevent this condition, allergic and high-risk infants require formulas where potentially allergy-inducing epitopes have been destroyed or reduced by hydrolysis.
 
We offer a broad portfolio and are able to tailor-make high quality hydrolysates. Our hydrolysates meet the demands of legislation and consumers with regard to health and safety. All our extensive whey hydrolysates have passed the active systemic anaphylaxis (ASA) test required by the EC directive for hydrolysates used for hypoallergenic formulas.

Related products: Peptigen® IF-3090 and Peptigen® IF-3080.

Nentwich et al. 2003. Klin Padiatr. 215: 275-279, Nentwich et al. 2009. Klin Padiatr. 221: 78-82.

Arla Foods Ingredients supports the WHO recommendation for exclusive breastfeeding for the first six months of an infant’s life and continued breastfeeding up to the age of two or beyond in combination with nutritionally appropriate complementary foods.